Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06316284

miRNA in Chronic Kidney Diseases

The Role of miRNAs in the Regulation of Oxidative Stress and Microvascular Reactivity in Chronic Kidney Disease

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Josip Juraj Strossmayer University of Osijek · Academic / Other
Sex
All
Age
18 Years – 69 Years
Healthy volunteers
Accepted

Summary

Oxidative stress and endoplasmic reticulum (ER) stress play a key role in tubular damage in both acute kidney injury and chronic kidney disease (CKD). Oxidative stress in the kidneys promotes renal vascular remodeling and increases preglomerular resistance. These are key elements in hypertension, acute and chronic kidney injury, as well as diabetic nephropathy. Chronic renal hypoxia is highlighted as the final common pathway to end-stage renal disease (ESRD). MicroRNA molecules (miRNA) also play an important role in these processes. MicroRNAs (miRNAs) are regulators of gene expression and play a role in the progression of renal ischemia-reperfusion injury. Although the pathophysiological contribution of microRNAs (miRNAs) to kidney damage has also been highlighted, the effect of miRNAs on kidney damage under conditions of oxidative and ER stress remains understudied.

Conditions

Timeline

Start date
2024-04-01
Primary completion
2025-12-31
Completion
2026-12-31
First posted
2024-03-18
Last updated
2024-03-18

Locations

1 site across 1 country: Croatia

Source: ClinicalTrials.gov record NCT06316284. Inclusion in this directory is not an endorsement.